XPH stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Intra-Cellular Therapies (NASDAQ:ITCI).

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

The average market capitalization across the SPDR® S&P Pharmaceuticals ETF ETF is 127.78B. The market cap for tickers in the group ranges from 4.35B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is PRGO at 4.35B.

The average weekly price growth across all stocks in the SPDR® S&P Pharmaceuticals ETF ETF was -6%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was 10%. AXSM experienced the highest price growth at 3%, while LLY experienced the biggest fall at -10%.

The average weekly volume growth across all stocks in the SPDR® S&P Pharmaceuticals ETF ETF was 93%. For the same stocks of the ETF, the average monthly volume growth was 290% and the average quarterly volume growth was 281%